Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43 - Clinical Trial Not Allowed)
The summary for the Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43 - Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43 - Clinical Trial Not Allowed): This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose preclinical studies to advance the development of biomarkers or treatments for rare musculoskeletal, rheumatic or skin diseases. Rare diseases have a prevalence of fewer than 200,000 affected individuals in the United States. Also eligible for potential funding through this initiative are studies of FDA-designated orphan products for musculoskeletal, rheumatic or skin diseases.
|Federal Grant Title:||Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43 - Clinical Trial Not Allowed)|
|Federal Agency Name:||National Institutes of Health (HHS-NIH11)|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-AR-20-003|
|Type of Funding:||Grant|
|CFDA Descriptions:||Information not provided|
|Current Application Deadline:||July 10th, 2019|
|Original Application Deadline:||July 10th, 2019|
|Posted Date:||April 26th, 2019|
|Creation Date:||April 26th, 2019|
|Archive Date:||August 15th, 2019|
|Total Program Funding:|
|Maximum Federal Grant Award:||$250,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
|Last Updated:||April 26th, 2019|
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding announcement for eligibility details
- Link to Full Grant Announcement
- Grant Announcement Contact
- NIH OER Webmaster
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Similar Government Grants
- • Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed...
- • Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed...
- • Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)
- • Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)- Clinical Tr...
- • Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal D...
- • Collaborative Arthritis and Musculoskeletal and Skin Diseases Science Award (Camssa)
- • Niams Small Grant Program for New Investigators
- • Skin Diseases Research Core Centers
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...